Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Fax written comments on the collection of information by February 24, 2014.
To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: Start Printed Page 3820202-395-7285, or emailed to email@example.com. All comments should be identified with the OMB control number 0910-0551. Also include the FDA docket number found in brackets in the heading of this document.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, PRAStaff@fda.hhs.gov.
End Further Info
Start Supplemental Information
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Application for Participation in the Medical Device Fellowship Program—(OMB Control Number 0910-0551)—(Extension)
Sections 1104, 1302, 3301, 3304, 3320, 3361, 3393, and 3394 of Title 5 of the United States Code authorize Federal Agencies to rate applicants for Federal jobs. Collecting applications for the Medical Device Fellowship Program will allow FDA's Center for Devices and Radiological Health (CDRH) to easily and efficiently elicit and review information from students and health care professionals who are interested in becoming involved in CDRH activities. The process will reduce the time and cost of submitting written documentation to the Agency and lessen the likelihood of applications being misrouted within the Agency mail system. It will assist the Agency in promoting and protecting the public health by encouraging outside persons to share their expertise with CDRH.
In the Federal Register of September 10, 2013 (78 FR 55260), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.
FDA based these estimates on the number of inquiries that have been received concerning the program and the number of requests for application forms over the past 3 years.
FDA estimates the burden of this collection of information as follows:
Table 1—Estimated Annual Reporting Burden
|FDA form No.||Number of respondents||Number of responses per
respondent||Total annual responses||Average burden per
|Application Form (Form FDA 3608)||250||1||250||1||250|
|1 There are no capital costs or operating and maintenance costs associated with this collection of information.|
End Supplemental Information
Dated: January 16, 2014.
Assistant Commissioner for Policy.
[FR Doc. 2014-01221 Filed 1-22-14; 8:45 am]
BILLING CODE 4160-01-P